Sleep medicine · 2019
Diagnosing obstructive sleep apnea patients with isolated nocturnal hypoventilation and defining obesity hypoventilation syndrome using new European Respiratory Society classification criteria: an Indian perspective.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Goyal Abhishek, Pakhare Abhijit, Tiwari Ishan Raj, Khurana Alkesh, Chaudhary Poonam
Аннотация
BACKGROUND: Recently, new classification criteria for obesity hypoventilation syndrome (OHS) have been described. OHS prevalence according to new criteria has not been reported in obstructive sleep apnea (OSA). Prevalence of OHS has not been previously reported from India.
METHODS: Retrospective study was carried out in OSA patients for whom both arterial blood gases (ABG) and end-tidal CO2 (etCO2) records were available. OHS was defined according to old and new criteria. Analysis was carried out among various groups: patients without OHS (Group A), patients with sleep hypoventilation but without daytime hypercapnia (Group B) and patients with daytime hypercapnia (Group C).
RESULTS: Out of 367 patients with OSA (body mass index, BMI) 31.9 ± 12.27 kg/m2), finally 128 obese OSA patients were included for analysis. Of those, 15 (5.9%, 95% confidence interval (CI) 3.5-9.4) and 45 patients (17.8%, 95% CI 13.4-22.9) fulfilled prevalence of OHS according to old and new criteria, respectively. Continuous positive airway pressure (CPAP) titration failed in 9.6%, 53.3% and 66.7% in Groups A, B, and C, respectively. For all parameters of OSA severity (apnea-hypopnea index (AHI), Nadir O2, T90) and positive airway pressure (PAP) requirements, patients in Group B were in between those in Groups A and C. Statistically significant difference was seen between Group A and Group B, and between Groups A and C, but not between Groups B and C.
CONCLUSION: One in six OSA patients and one in three obese OSA patients (BMI >30 kg/m2) have OHS according to new criteria. Since patients with isolated nocturnal hypoventilation were as sick as patients with daytime hypercapnia, screening for sleep hypoventilation should be carried out in all obese OSA patients.
METHODS: Retrospective study was carried out in OSA patients for whom both arterial blood gases (ABG) and end-tidal CO2 (etCO2) records were available. OHS was defined according to old and new criteria. Analysis was carried out among various groups: patients without OHS (Group A), patients with sleep hypoventilation but without daytime hypercapnia (Group B) and patients with daytime hypercapnia (Group C).
RESULTS: Out of 367 patients with OSA (body mass index, BMI) 31.9 ± 12.27 kg/m2), finally 128 obese OSA patients were included for analysis. Of those, 15 (5.9%, 95% confidence interval (CI) 3.5-9.4) and 45 patients (17.8%, 95% CI 13.4-22.9) fulfilled prevalence of OHS according to old and new criteria, respectively. Continuous positive airway pressure (CPAP) titration failed in 9.6%, 53.3% and 66.7% in Groups A, B, and C, respectively. For all parameters of OSA severity (apnea-hypopnea index (AHI), Nadir O2, T90) and positive airway pressure (PAP) requirements, patients in Group B were in between those in Groups A and C. Statistically significant difference was seen between Group A and Group B, and between Groups A and C, but not between Groups B and C.
CONCLUSION: One in six OSA patients and one in three obese OSA patients (BMI >30 kg/m2) have OHS according to new criteria. Since patients with isolated nocturnal hypoventilation were as sick as patients with daytime hypercapnia, screening for sleep hypoventilation should be carried out in all obese OSA patients.